Yemaachi Biotechnology logo

Yemaachi Biotechnology

Emerging

Precision oncology biotech developing African population-specific cancer diagnostics; $25M Cancer Grand Challenges award with Roche partnership on The African Cancer Atlas in Ghana.

39
AI Score
Grade D↑ Trending
AI Visibility Score (Beta)
HealthcareWebsiteUpdated March 2026

Company Overview

About Yemaachi Biotechnology

Yemaachi Biotechnology is a precision oncology company applying immunogenomics, bioinformatics, and AI to develop cancer diagnostics and treatments specifically calibrated for African and African-descent populations — addressing the critical gap in oncology research where most cancer data and therapies have been developed on predominantly European-ancestry patient populations, leaving African patients underserved by current diagnostic tools and treatment protocols. Founded and backed by Y Combinator, Yemaachi is based in Accra, Ghana and has raised $29+ million including a $25 million Cancer Grand Challenges award and a $3 million seed round led by V8 Capital.

Business Model & Competitive Advantage

Yemaachi's research platform combines the collection of cancer genomics data from African patients (building one of the largest African cancer biobanks) with AI analysis to identify genomic variants, immune signatures, and biomarkers specific to African populations. This enables the development of diagnostic tests calibrated for African-specific tumor biology and the identification of therapeutic targets that may differ from European-ancestry cancer drivers. The company launched the Sheba HPV Test in Ghana (cervical cancer screening) and is partnering with Roche on The African Cancer Atlas — a comprehensive genomic characterization of cancer across Africa.

Competitive Landscape 2025–2026

In 2025, Yemaachi operates at the intersection of oncology research, diagnostics, and population genomics for an underserved market. Cancer is a growing health crisis across sub-Saharan Africa, where late-stage diagnosis is the norm due to limited screening infrastructure and the poor sensitivity of Western-developed tests on African patients. Yemaachi's approach — building African-specific cancer intelligence — positions the company as both a research institution and a commercial diagnostics provider. The 2025 strategy focuses on expanding the African Cancer Atlas partnership with Roche, launching additional HPV and cancer screening products across West Africa, and partnering with global pharma companies seeking to include African populations in clinical trials.

Headquarters
Accra, Ghana
Curated content • Fact-checked and verified

Recent Activity

View all →

Key Differentiators

Emerging Innovator

Yemaachi Biotechnology is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

39
↑ Trending

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Browser Use logo

Browser Use

Developer Tools
B2bDeveloper ToolsPlatformSaasStartup

Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom

athenahealth logo

athenahealth

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on

Veeva Systems logo

Veeva Systems

Healthcare Tech
B2bHealthtechSaasPublic

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv

Oracle Health logo

Oracle Health

Healthcare
HealthtechNorth AmericaB2b

Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve

Idexx Laboratories logo

Idexx Laboratories

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu

Revvity logo

Revvity

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid

For Yemaachi Biotechnology

Claim This Profile

Are you from Yemaachi Biotechnology? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Yemaachi Biotechnology Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Yemaachi Biotechnology vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →